- Home
- ATLO vs ALDX Comparison
ATLO vs ALDX Comparison
Compare ATLO & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLO
- ALDX
- Stock Information
- Founded
- ATLO 1903
- ALDX 2004
- Country
- ATLO United States
- ALDX United States
- Employees
- ATLO N/A
- ALDX N/A
- Industry
- ATLO Major Banks
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- ATLO Finance
- ALDX Health Care
- Exchange
- ATLO Nasdaq
- ALDX Nasdaq
- Market Cap
- ATLO 158.4M
- ALDX 160.8M
- IPO Year
- ATLO N/A
- ALDX 2014
- Fundamental
- Price
- ATLO $18.16
- ALDX $3.93
- Analyst Decision
- ATLO
- ALDX Strong Buy
- Analyst Count
- ATLO 0
- ALDX 2
- Target Price
- ATLO N/A
- ALDX $9.50
- AVG Volume (30 Days)
- ATLO 16.2K
- ALDX 993.4K
- Earning Date
- ATLO 08-08-2025
- ALDX 07-31-2025
- Dividend Yield
- ATLO 4.49%
- ALDX N/A
- EPS Growth
- ATLO 14.69
- ALDX N/A
- EPS
- ATLO 1.27
- ALDX N/A
- Revenue
- ATLO $55,041,000.00
- ALDX N/A
- Revenue This Year
- ATLO N/A
- ALDX N/A
- Revenue Next Year
- ATLO N/A
- ALDX N/A
- P/E Ratio
- ATLO $14.07
- ALDX N/A
- Revenue Growth
- ATLO 6.77
- ALDX N/A
- 52 Week Low
- ATLO $15.69
- ALDX $1.14
- 52 Week High
- ATLO $22.03
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- ATLO 54.10
- ALDX 73.08
- Support Level
- ATLO $17.19
- ALDX $3.68
- Resistance Level
- ATLO $17.67
- ALDX $4.00
- Average True Range (ATR)
- ATLO 0.37
- ALDX 0.28
- MACD
- ATLO 0.02
- ALDX 0.10
- Stochastic Oscillator
- ATLO 89.69
- ALDX 86.38
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.